About 200 reports

Tier ##: revenue > USD ## billion; tier ##: USD ## million ≤ revenue ≤ USD ## billion; tier ##: revenue < USD ## million.

  • Vitamin
  • Amway Corporation
  • ConAgra Foods, Inc.
  • General Mills, Inc.
  • The Kraft Heinz Company

Immunology sales increased, led by Xolair and Actemra/ RoActemra.

  • Leukemia
  • Incyte Corporation
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group

It deals in a variety of therapies of anti-infectives, inflammation and immunology, internal medicine, and oncology.

  • Vitamin
  • Amway Corporation
  • Bayer AG
  • Pfizer Inc.
  • Procter & Gamble Company

Figure ##.

  • Vitamin
  • United States
  • Amway Corporation
  • Chobani LLC
  • Herbalife Ltd.

IT PROVIDES PHARMACEUTICALS IN CANCER, NEUROSCIENCE, INFECTION, IMMUNOLOGY, OPHTHALMOLOGY, CARDIOVASCULAR AND METABOLISM, IMMUNOLOGY, HEMATOLOGY, HEMOPHILIA AND RESPIRATORY DISEASE AREAS.

  • Vitamin
  • Brazil
  • Russia
  • Forecast
  • Market Segment

According to the Colombian Association of Allergy and Immunology there are between four and five million Colombians suffering from food allergies.

  • Vitamin
  • Colombia
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Tecnoquímicas SA

According to the Sociedade Portuguesa de Alergologia e Imunologia Clínica (Portuguese Society of Allergology and Clinical Immunology - SPAIC), more and more people are suffering from respiratory allergies, especially rhinitis.

  • Vitamin
  • Portugal
  • Demand
  • GlaxoSmithKline plc
  • Unipessoal, Lda

IT PROVIDES PHARMACEUTICALS IN CANCER, NEUROSCIENCE, INFECTION, IMMUNOLOGY, OPHTHALMOLOGY, CARDIOVASCULAR AND METABOLISM, IMMUNOLOGY, HEMATOLOGY, HEMOPHILIA AND RESPIRATORY DISEASE AREAS.

  • Vitamin
  • East Asia
  • Forecast
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.

FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY ##.

  • Leukemia
  • Vitamin
  • Company
  • Market Size
  • Juno Therapeutics Inc.
  • C) Late-stage pipeline developers by level of immunology specialization
  • HEMATOLOGICAL CANCERS THERAPEUTICS MARKET, GLOBAL, APPROVED INDICATIONS FOR

Seminars in Immunology; ##: ##-## Lao Z, et al. (2015).

  • Leukemia
  • Market Size
  • Celgene Corporation
  • Novartis AG
  • Roche Group

THERE IS A CLEAR FOCUS ON INVESTING IN IMMUNOLOGY DEVELOPMENT.

  • Leukemia
  • Vitamin
  • AstraZeneca PLC
  • Novartis AG
  • Pfizer Inc.

IN ##, PAUL EHRLICH, WHO IS CONSIDERED TO BE THE FATHER OF MODERN IMMUNOLOGY, PROPOSED THE SIDE-CHAIN THEORY THAT HYPOTHESIZED THAT SIDE CHAIN RECEPTORS ON CELLS BIND TO A GIVEN PATHOGEN.

  • Leukemia
  • North America
  • United States
  • Ablynx NV
  • Amgen Inc.
  • Versatile Innovation in Hematological Cancers Therapeutics Market, Global, First-in-Class Programs in Active Development Without
  • Alignment within Hematological Cancers

Advances in Immunology; ##; ##-## EBI (2017).

  • Leukemia
  • Vitamin
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Novartis AG
  • 11.1 BIBLIOGRAPHY

CANCER IMMUNOLOGY, IMMUNOTHERAPY; ##(##): ##-##.

  • Leukemia
  • Astellas Pharma Inc.
  • Astex Pharmaceuticals, Inc.
  • Celgene Corporation
  • Novartis AG

Some players compete by increasing their range of products and employing direct sales agents, who deal with retailers one-on-one.

  • OTC
  • Vitamin
  • Cameroon
  • Demand
  • Sanofi S.A.
  • Hematological Cancers
  • Hematological Cancers Therapeutics Market, Global, First-in-Class Targets Not Involved in Deals, Part 4, 2016

Immunology; ##: ##-## Melchers F (2006).

  • Leukemia
  • Market Size
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Novartis AG

The prominent features of this report are - ##.

  • Cell Therapy
  • Leukemia
  • Medical Biotechnology
  • World
  • Product Initiative
  • Official Title

The prominent features of this report are - ##.

  • Blood Disease
  • Leukemia
  • Vitamin
  • World
  • Product Initiative
  • Clinical Trial profile. 307 Trial Title
  • Clinical Trial profile. 235 Trial Title

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Bellicum Pharmaceuticals Inc ## ##

  • Leukemia
  • Monoclonal Antibody
  • Vitamin
  • United States
  • World

With three major research centres located in Germany, Austria and the US, the company' s main areas of development are focused on immunology and diseases of the respiratory, cardio-metabolic and central nervous systems as well as non-clinical drug development.

  • Vitamin
  • Brazil
  • Demand
  • Farmacêutica Ltda
  • Sanofi S.A.

The company will however focus new product development on Rx medicines, with a focus on rare diseases, diabetes, cardiovascular diseases and immunology.

  • OTC
  • Vitamin
  • Italy
  • Demand
  • Angelini Group
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2018 (CONTD..4), H2 2018
  • DORMANT PRODUCTS, H2 2018 (CONTD..3), H2 2018

Its primary focus is on cancer, cardiovascular, immunology and virology (including hepatitis B, hepatitis C and HIV infection) therapeutic projects.

  • Leukemia
  • Therapy
  • United States
  • Product Initiative
  • Incyte Corporation
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018 (CONTD..4), H1 2018
  • DORMANT PRODUCTS, H1 2018 (CONTD..3), H1 2018

" We are pleased to share data underscoring the potential of our immunology portfolio. "

  • Leukemia
  • Vitamin
  • United States
  • Product Initiative
  • Incyte Corporation

The segment recorded ##% sales growth in oncology therapeutic area and ##% in immunology.

  • Dietary Supplement
  • Leukemia
  • Vitamin
  • Europe
  • DiaSorin S.p.A.

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Leukemia
  • Therapy
  • United States
  • World
  • Product Initiative
  • Clinical Trial profile. 258 Trial Title

## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## Canada Source: GlobalData' s Phar

  • Leukemia
  • Medical Biotechnology
  • Vitamin
  • World
  • Product Initiative
  • PIPELINE BY SYNIMMUNE GMBH, H1 2019
  • PIPELINE BY SYNIMMUNE GMBH, H1 2018

Immune Tolerance Network announced the AbATE study Phase II results in type ## diabetes were published in Science Immunology.

  • Leukemia
  • United States
  • World
  • Product Initiative
  • Amgen Inc.
  • Introduction

One CRi.

  • Acne Treatment
  • Leukemia
  • Vitamin
  • Product Initiative
  • Syros Pharmaceuticals, Inc.

Lancet Oncology, ##(##), ##-##.

  • Leukemia
  • Amgen Inc.
  • ARIAD Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer Inc.

The patients will be randomized ##:## to receive either resminostat or placebo.

  • Leukemia
  • Targeted Therapy
  • United States
  • World
  • Product Initiative